Copeptin a Potential Biomarker of Symptom Severity During Pulmonary Exacerbation, Study Shows

High levels of the peptide copeptin are associated with increased severity of cystic fibrosis (CF) in children, a study shows. These results suggest that copeptin can be used as a biomarker to identify patients who could benefit from more aggressive treatment. The study, titled “Evaluation of…